Fulgent Genetics (FLGT) Other Non-Current Liabilities (2016 - 2026)

Fulgent Genetics has disclosed Other Non-Current Liabilities across 10 years of filings, most recently posting $9.0 million for Q2 2026.

• In Q2 2026, Other Non-Current Liabilities rose 51.94% year-over-year to $9.0 million; the TTM figure through Jun 2026 stood at $9.0 million (up 51.94% YoY), while the FY2025 annual figure was $7.6 million, up 9.34% from the prior year.
• Other Non-Current Liabilities came in at $9.0 million for Q2 2026 at Fulgent Genetics, down from $9.4 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $21.7 million in Q2 2022 to a low of $5.9 million in Q2 2025.
• Average Other Non-Current Liabilities over 5 years is $12.5 million, with a median of $12.9 million recorded in 2024.
• Year-over-year, Other Non-Current Liabilities soared 1792.01% in 2022 and plunged 58.98% in 2025.
• Over 5 years, Other Non-Current Liabilities stood at $18.2 million in 2022, then retreated by 17.28% to $15.1 million in 2023, then sank by 53.77% to $7.0 million in 2024, then increased by 9.34% to $7.6 million in 2025, then advanced by 17.68% to $9.0 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $9.0 million in Q2 2026, $9.4 million in Q1 2026, and $7.6 million in Q4 2025.